Mendel Money Management
Source: SEC Form 13F · as of Mar 2026Mendel Money Management holds 11 biotech & pharma companies tracked by BioSniper, totaling $11.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$11.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 10,942 | $2.4M |
| LLYELI LILLY & Co | 1,612 | $1.5M |
| AMGNAMGEN INC | 4,005 | $1.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,527 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 8,787 | $1.2M |
| MRKMerck & Co., Inc. | 8,796 | $1.1M |
| JNJJOHNSON & JOHNSON | 4,294 | $1.0M |
| BMYBRISTOL MYERS SQUIBB CO | 8,655 | $525K |
| ABTABBOTT LABORATORIES | 4,000 | $411K |
| GHGuardant Health Inc. | 3,235 | $299K |
| PFEPFIZER INC | 8,000 | $225K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.